Aberrant expression and distribution of the OCT-4 transcription factor in seminomas
- PMID: 17682839
- DOI: 10.1007/s11373-007-9198-7
Aberrant expression and distribution of the OCT-4 transcription factor in seminomas
Abstract
Testicular germ cell tumors (TGCTs), comprised of seminomas and non-seminomas, are derived from premalignant and noninvasive intracellular germ cell neoplasias. Among TGCTs, seminomas are believed to resemble a transformed state of primordial germ cells (PGCs) and are known to exhibit a gene expression profile similar to that of embryonic stem (ES) cells, such as transcription factor OCT-4. OCT-4 has recently been recognized as a diagnostic marker for clinical aspects of seminomas. However, the role of the OCT-4 protein in seminomas has not been clarified. To determine a possible role of the OCT-4 protein in seminomas, in this paper, we studied a series of 41 testicular tumor tissues and four cell lines by immunohistochemistry, Western blotting, and reverse-transcriptase polymerase chain reaction (RT-PCR) to examine the expression and distribution of the OCT-4 transcription factor in seminomas. By utilizing immunohistochemical staining and Western blotting, we demonstrated that the OCT-4 transcription factor was aberrantly localized in the cytoplasm and nuclei of cells in the collected seminoma tissues. This observation was further confirmed using immunocytochemical staining of NCCIT (seminoma-embryonal carcinoma) and NT2 (embryonal carcinoma) cells. In addition, the RT-PCR results indicated that Oct-4 mRNA was relatively highly expressed in NCCIT, NT2 cells, and seminoma tissues when compared with human embryonic stem cells. The aberrant expression and distribution of the OCT-4 transcription factor in seminomas may provide some important clues concerning the cell transformation between germ line stem cells (like PGC) and testicular germ cell tumors.
Similar articles
-
Estrogen receptor-beta expression in human testicular germ cell tumors.Clin Cancer Res. 2003 Oct 1;9(12):4475-82. Clin Cancer Res. 2003. PMID: 14555521
-
Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma.Int J Androl. 2010 Feb;33(1):54-63. doi: 10.1111/j.1365-2605.2009.00950.x. Epub 2009 Feb 10. Int J Androl. 2010. PMID: 19226408
-
c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.J Pathol. 2007 Nov;213(3):311-8. doi: 10.1002/path.2225. J Pathol. 2007. PMID: 17768701
-
Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.J Pathol. 2009 Jun;218(2):146-62. doi: 10.1002/path.2522. J Pathol. 2009. PMID: 19253916 Review.
-
Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.Ann N Y Acad Sci. 2007 Dec;1120:187-214. doi: 10.1196/annals.1411.000. Epub 2007 Oct 2. Ann N Y Acad Sci. 2007. PMID: 17911410 Review.
Cited by
-
Fermented Ginseng Extract, BST204, Suppresses Tumorigenesis and Migration of Embryonic Carcinoma through Inhibition of Cancer Stem Cell Properties.Molecules. 2020 Jul 8;25(14):3128. doi: 10.3390/molecules25143128. Molecules. 2020. PMID: 32650569 Free PMC article.
-
Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.Cell Tissue Res. 2023 Oct;394(1):189-207. doi: 10.1007/s00441-023-03813-2. Epub 2023 Aug 12. Cell Tissue Res. 2023. PMID: 37572165 Free PMC article.
-
RNA-Binding Proteins Play an Important Role in the Prognosis of Patients With Testicular Germ Cell Tumor.Front Genet. 2021 Mar 11;12:610291. doi: 10.3389/fgene.2021.610291. eCollection 2021. Front Genet. 2021. PMID: 33777092 Free PMC article.
-
Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.J Zhejiang Univ Sci B. 2011 Oct;12(10):812-9. doi: 10.1631/jzus.B1100059. J Zhejiang Univ Sci B. 2011. PMID: 21960344 Free PMC article.
-
Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection.Int J Mol Sci. 2014 Jul 18;15(7):12764-77. doi: 10.3390/ijms150712764. Int J Mol Sci. 2014. PMID: 25046748 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical